ABSTRACT
introduction
Giant cell tumour of bone is benign, aggressive, and metastasising. Surgical removal of the tumour is the mainstay of treatment. Intralesional curettage alone has a recurrence rate of 15% to 25%.
1,2 Adjunct treatment using phenol, liquid nitrogen, bone cement, and radiotherapy is thus recommended. [3] [4] [5] [6] In tumours with extensive soft tissue involvement, these adjunct treatments may damage surrounding soft tissue, including neurovascular bundles. Giant cell tumour of bone cells are more vulnerable to thermoablation than osteoblasts and chondrocytes.
signs of apoptosis after thermoablation. 7 Adjunct treatment using caffeine has achieved good results in colon cancer,8 skin cancer, 9 connective tissue sarcoma, and osteosarcoma [10] [11] [12] [13] [14] [15] [16] Caffeine increases the susceptibility of tumour cells to chemotherapy. 17 This study evaluated the effect of caffeine on the apoptosis rate of giant cell tumour of bone cells during thermoablation.
Materials and Methods
This study was approved by the institutional review board of our hospital. Giant cell tumour of bone tissue (2 cm 3 ) was collected from 10 patients. The tissue was minced and then digested with 0.15 mg/ ml collagenase in serum-free DMEM supplemented with 100 U/ml penicillin and 100 µg/ml streptomycin for 60 minutes at 37ºC. The digested tissue was then washed 3 times with 10% DMEM at 2000 rpm centrifugation for 5 minutes to prepare a tumour cell suspension in 10% DMEM. The total number of cells was counted using a haemacytometer.
Cell suspension at 1x10 6 cells/ml was transferred in aliquots of 300 µl into each 0.5 ml Eppendorf tube and then incubated at 37ºC, 40ºC, 45ºC, 50ºC, 52.5ºC, and 55ºC for 20 minutes (3 tubes for each temperature). Caffeine was added to the tubes in amounts of 0 µg/ml (control), 50 µg/ml, and 100 µg/ ml. The cells in each tube were seeded on each well at 300 000 cells/well and incubated in a CO 2 incubator at 37ºC for 2 further days.
Cytotoxic activity of all cell types (multi-and mono-nucleated giant tumour cells and stromal cells) was measured using the Annexin V-FITC apoptosis detection kit (Sigma, St Louis [MO], USA). Most of the cells in this short-term culture were tumour cells. 7 The cells were re-suspended in 500 µl of binding buffer. The cell suspension was stained with 5 µl of Annexin V-FITC and 10 µl of propidium iodide solution. The tube was incubated at room temperature for 10 minutes under light protection conditions. The cell suspension was assessed for fluorescence intensity using a flow cytometer (FACS Calibur, BD Biosciences) [ Fig.] . The apoptotic effect of thermoablation with or without caffeine was evaluated using 2-way ANOVA. Subgroup analysis was performed using Dunnett's T3 test. A p value of <0.05 was considered statistically significant.
results
In all test conditions, the apoptotic rate of tumour cells increased when the temperature increased from 37ºC to 52.5ºC (Table 1) . From 52.5ºC to 55ºC, the
Figure
The suspension of multi-and mono-nucleated giant tumour cells and stromal cells as assessed for fluorescence intensity using a flow cytometer. The dense area is used for determination of cell survival. Table  2 . Compared with controls (no caffeine), adding 50 or 100 µg/ml of caffeine did not increase the apoptotic rate significantly at 40ºC to 52.5ºC (Table 1) . Caffeine had no enhancing effect at any temperature. Conversely, at 55ºC, the apoptotic rate was lower when 100 µg/ml of caffeine was added than when no or 50 µg/ml of caffeine added (p=0.045).
discussion
Caffeine can enhance the cytocidal effects of anticancer drugs through its DNA repair-inhibiting effects in osteosarcoma. 18 Caffeine can also activate the immune response via NK-cell recruitment, 19 and tumour suppressor genes PTEN in sarcoma.
14 Serum concentration of caffeine can also be controlled. 20 Caffeine can enhance cytotoxicity to tumour cells under mild hyperthermia. 21 The therapeutic serum concentration of caffeine should not be >80 µg/ml. 18 At high temperatures, caffeine has cytoprotective effects on normal and tumour cells against thermoablation, chemotherapy, and radiation. [22] [23] [24] Caffeine induces heat shock proteins to protect various cells under stressful conditions. [25] [26] [27] [28] Therefore, caffeine should be discontinued during chemotherapy for malignant tumours. 29 Caffeine consumption should be avoided in patients undergoing thermoablation.
During thermoablation, most normal cells can produce heat shock proteins to stabilise most intracellular polypeptides. Tumour stem cells are primitive cells and may not be able to produce adequate heat shock proteins. [30] [31] [32] [33] Thermoablation at >42ºC for variable times can damage the DNA of tumour cells. 34 Thermoablation can activate and enhance the immune response of the body to particular sarcoma. 35, 36 Thermoablation can also potentiate the effectiveness of some chemotherapy agents. 37 Giant cell tumour of bone is a thermo-sensitive tumour. 7 In our study, the optimum temperature and duration for thermoablation was found to be 50ºC for 20 minutes.
conclusion
Thermoablation at 40ºC to 52.5ºC for 20 minutes increased the apoptosis rate of giant cell tumour of bone cells. Caffeine had no enhancing effect at any temperature. Conversely, at 55ºC, caffeine had cytoprotective effects on the tumour cells against thermoablation.
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